The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients

about

BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from Chernobyl

P2860

Q36301491-8F9F43EB-DC3B-4D3C-87F2-2819EA5B5C18

P2860

The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients

Item

http://www.wikidata.org/entity/Q35932262

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The Clinicopathological Featur ...... id Cancers in Chinese Patients

@ast

The Clinicopathological Featur ...... id Cancers in Chinese Patients

@en

type

Item

label

The Clinicopathological Featur ...... id Cancers in Chinese Patients

@ast

The Clinicopathological Featur ...... id Cancers in Chinese Patients

@en

prefLabel

The Clinicopathological Featur ...... id Cancers in Chinese Patients

@ast

The Clinicopathological Featur ...... id Cancers in Chinese Patients

@en

P1476

The Clinicopathological Featur ...... id Cancers in Chinese Patients

@en

P2093

Feng Ye

http://www.w3.org/2001/XMLSchema#string

Hong Bu

http://www.w3.org/2001/XMLSchema#string

Hong-Ying Zhang

http://www.w3.org/2001/XMLSchema#string

Li-Bo Yang

http://www.w3.org/2001/XMLSchema#string

Lin-Yong Sun

http://www.w3.org/2001/XMLSchema#string

Ying Tang

http://www.w3.org/2001/XMLSchema#string

Yong Jiang

http://www.w3.org/2001/XMLSchema#string

Zhi-Hui Li

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer

The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer

Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

Impact of molecular testing in the diagnosis of thyroid fine needle aspiration cytology: data from mainland China.

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling.

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

P304

642046

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/642046

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281056396

http://www.w3.org/2001/XMLSchema#string

P698

26273300

http://www.w3.org/2001/XMLSchema#string

P932

4530233

http://www.w3.org/2001/XMLSchema#string

The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients

about

P2860

P2860

The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932